These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28431062)

  • 1. Impact of basal inferolateral scar burden determined by automatic analysis of 99mTc-MIBI myocardial perfusion SPECT on the long-term prognosis of cardiac resynchronization therapy.
    Morishima I; Okumura K; Tsuboi H; Morita Y; Takagi K; Yoshida R; Nagai H; Tomomatsu T; Ikai Y; Terada K; Sone T; Murohara T
    Europace; 2017 Apr; 19(4):573-580. PubMed ID: 28431062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of Left Ventricular Remodeling and Regional Dyssynchrony on Long-Term Prognosis after Cardiac Resynchronization Therapy.
    Tayal B; Sogaard P; Delgado-Montero A; Goda A; Saba S; Risum N; Gorcsan J
    J Am Soc Echocardiogr; 2017 Mar; 30(3):244-250. PubMed ID: 27986357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yield of left ventricular dyssynchrony by gated SPECT MPI in patients with heart failure prior to implantable cardioverter-defibrillator or cardiac resynchronization therapy with a defibrillator: Characteristics and prediction of cardiac outcome.
    Zafrir N; Bental T; Strasberg B; Solodky A; Mats I; Gutstein A; Kornowski R
    J Nucl Cardiol; 2017 Feb; 24(1):122-129. PubMed ID: 26563336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of scar burden by single-photon emission computed tomography myocardial perfusion imaging on patient outcomes following cardiac resynchronization therapy.
    Adelstein EC; Tanaka H; Soman P; Miske G; Haberman SC; Saba SF; Gorcsan J
    Eur Heart J; 2011 Jan; 32(1):93-103. PubMed ID: 20971745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The possible role of nuclear imaging in assessment of the cardiac resynchronization therapy effectiveness in patients with moderate heart failure.
    Lishmanov Y; Minin S; Efimova I; Chernov V; Saushkina Y; Lebedev D; Popov S
    Ann Nucl Med; 2013 May; 27(4):378-85. PubMed ID: 23456177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging is superior to cardiac scintigraphy to identify nonresponders to cardiac resynchronization therapy.
    Yokokawa M; Tada H; Toyama T; Koyama K; Naito S; Oshima S; Taniguchi K
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S57-62. PubMed ID: 19250113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors and Clinical Outcomes of Transient Responders to Cardiac Resynchronization Therapy.
    Ichibori H; Fukuzawa K; Kiuchi K; Matsumoto A; Konishi H; Imada H; Hyogo K; Kurose J; Tatsumi K; Tanaka H; Hirata KI
    Pacing Clin Electrophysiol; 2017 Mar; 40(3):301-309. PubMed ID: 28083969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative gated SPECT-derived phase analysis on gated myocardial perfusion SPECT detects left ventricular dyssynchrony and predicts response to cardiac resynchronization therapy.
    Boogers MM; Van Kriekinge SD; Henneman MM; Ypenburg C; Van Bommel RJ; Boersma E; Dibbets-Schneider P; Stokkel MP; Schalij MJ; Berman DS; Germano G; Bax JJ
    J Nucl Med; 2009 May; 50(5):718-25. PubMed ID: 19403876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Echocardiographic myocardial scar burden predicts response to cardiac resynchronization therapy in ischemic heart failure.
    Mele D; Agricola E; Galderisi M; Rigo F; Citro R; Dal Monte A; Della Valentina P; Calabrese A; Ferrari R;
    J Am Soc Echocardiogr; 2009 Jun; 22(6):702-8. PubMed ID: 19423292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac resynchronization therapy evaluated by myocardial scintigraphy with 99mTc-MIBI: changes in left ventricular uptake, dyssynchrony, and function.
    Brandão SC; Nishioka SA; Giorgi MC; Chen J; Abe R; Martinelli Filho M; Hotta VT; Vieira ML; Garcia EV; Meneghetti JC
    Eur J Nucl Med Mol Imaging; 2009 Jun; 36(6):986-96. PubMed ID: 19145431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac Resynchronization Therapy for Improving Non-Uniform Thickening of Left Ventricular Wall: Assessment by Quantitative Gated Myocardial Perfusion SPECT.
    Wakayama Y; Nakano M; Fukuda K; Kumagai K; Sugai Y; Hirose M; Yamaguchi N; Kondo M; Kaneta T; Fukuda H; Kagaya Y; Shimokawa H
    Tohoku J Exp Med; 2020 Jun; 251(2):69-79. PubMed ID: 32493869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of ECG-gated SPECT imaging in patients undergoing stress Tc-99m sestamibi myocardial perfusion imaging.
    Travin MI; Heller GV; Johnson LL; Katten D; Ahlberg AW; Isasi CR; Kaplan RC; Taub CC; Demus D
    J Nucl Cardiol; 2004; 11(3):253-62. PubMed ID: 15173772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of myocardial viability and left ventricular lead location on clinical outcome in cardiac resynchronization therapy recipients with ischemic cardiomyopathy.
    Bose A; Kandala J; Upadhyay GA; Riedl L; Ahmado I; Padmanabhan R; Gewirtz H; Mulligan LJ; Singh JP
    J Cardiovasc Electrophysiol; 2014 May; 25(5):507-513. PubMed ID: 24350650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective pilot study to evaluate the relationship between acute change in left ventricular synchrony after cardiac resynchronization therapy and patient outcome using a single-injection gated SPECT protocol.
    Friehling M; Chen J; Saba S; Bazaz R; Schwartzman D; Adelstein EC; Garcia E; Follansbee W; Soman P
    Circ Cardiovasc Imaging; 2011 Sep; 4(5):532-9. PubMed ID: 21772007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of quantitative parameters of myocardial perfusion SPECT and ventricular arrhythmia in patients receiving cardiac resynchronization therapy.
    Hou PN; Tsai SC; Lin WY; Cheng CM; Chiang KF; Chang YC; Huang JL; Hung GU; Chen SA; Chen J
    Ann Nucl Med; 2015 Nov; 29(9):772-8. PubMed ID: 26194143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective prediction of response to cardiac resynchronization therapy using a novel program of gated myocardial perfusion single photon emission computed tomography.
    Nakamura K; Takami M; Shimabukuro M; Maesato A; Chinen I; Ishigaki S; Higa S; Keida T; Masuzaki H
    Europace; 2011 Dec; 13(12):1731-7. PubMed ID: 21873328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 201Tl and 99mTc-MIBI gated SPECT in patients with large perfusion defects and left ventricular dysfunction: comparison with equilibrium radionuclide angiography.
    Manrique A; Faraggi M; Véra P; Vilain D; Lebtahi R; Cribier A; Le Guludec D
    J Nucl Med; 1999 May; 40(5):805-9. PubMed ID: 10319754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the response to cardiac resynchronization therapy using 99mTc-tetrofosmin myocardial scintigraphy in patients with drug-refractory heart failure: additional value of the washout of 99mTc-tetrofosmin.
    Shigeru M; Fujiwara S; Takamine S; Yoshida A; Kawai H; Shiotani H; Hirata K
    Nucl Med Commun; 2014 Sep; 35(9):939-46. PubMed ID: 24977350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient ischemic dilation for coronary artery disease in quantitative analysis of same-day sestamibi myocardial perfusion SPECT.
    Xu Y; Arsanjani R; Clond M; Hyun M; Lemley M; Fish M; Germano G; Berman DS; Slomka PJ
    J Nucl Cardiol; 2012 Jun; 19(3):465-73. PubMed ID: 22399366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left-ventricular dyssynchrony evaluated by Tl-201 gated SPECT myocardial perfusion imaging: a comparison with Tc-99m sestamibi.
    Chen CC; Huang WS; Hung GU; Chen WC; Kao CH; Chen J
    Nucl Med Commun; 2013 Mar; 34(3):229-32. PubMed ID: 23238227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.